$42.77
1.25%
Nasdaq, Nov 16, 11:26 am EST. Market open.
ISIN
US85209E1091
Symbol
SPRB

Spruce Biosciences Inc Stock price

$43.31
+2.96 7.34% 1M
-14.24 24.74% 6M
-43.80 50.28% YTD
-69.26 61.53% 1Y
-37.69 46.53% 3Y
-285.57 86.83% 5Y
-1,081.69 96.15% 10Y
-1,081.69 96.15% 20Y
Nasdaq, Closing price Fri, Nov 13 2026
+0.42 0.98%
ISIN
US85209E1091
Symbol
SPRB
Industry

Is Spruce Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$124.5m
Enterprise Value
$35.3m
Net debt
positive
Cash
$96.3m
Shares outstanding
2.8m
Valuation
P/E
-
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
negative | negative
P/B
1.5
Financial Health
Equity Ratio
80.2%
Return on Equity
-91.7%
ROCE
-
ROIC
-
Debt/Equity
0.1
Share-Based Compensation & Dilution
SBC | % of Revenue
$3.7m | -
SBC as % of FCF
-
SBC Growth 1Y
42.8%
Share Count Growth 1Y
391.1%
Shareholder Yield
-
Financials
Revenue | estimate
- | $0.0
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow | ex SBC
$-42.8m | $-46.4m
Growth
Revenue | estimate
- | -
EBITDA
-
EBIT
-
Net Income
-
Free Cash Flow
16.9%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
-
FCF per Share
$-15.6
Short interest
18.7%
Employees
9
Rev per Employee
$0.0

Spruce Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Spruce Biosciences Inc forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a Spruce Biosciences Inc forecast:

Buy
93%
Hold
7%

Spruce Biosciences Inc Events

Past Events
NOV
9
Q3 2026 Earnings Call
7 days ago

Financial data from Spruce Biosciences Inc

Mar '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 18 18
27% 27%
-
- Research and Development Expense 16 16
65% 65%
-
-34 -34
42% 42%
-
- Depreciation and Amortization 0.27 0.27
575% 575%
-
EBIT (Operating Income) EBIT -34 -34
41% 41%
-
Net Profit -37 -37
33% 33%
-

In millions USD.

Don't miss a Thing! We will send you all news about Spruce Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Spruce Biosciences Inc Stock News

Neutral
Business Wire
●
7 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2026, and provided corporate updates. “We are executing with discipline as...
Neutral
Business Wire
●
7 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it has separated the company's CRHX-101 (formerly SPR-202) program into Adrenyx Biosciences, Inc. ("Adrenyx"), a newly formed wh...
Neutral
Business Wire
●
14 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will participate in a fireside chat at the Guggenheim 3rd Annual Healt...
More Spruce Biosciences Inc News

Company Profile

Spruce Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing novel therapies for rare diseases affecting the endocrine system. The company was founded in 2014 and is headquartered in Daly City, CA.

Head office United States
CEO Dr. Szwarcberg
Employees 9
Founded 2014
Website sprucebio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today